Medication Regimen Complexity In 8 Australian Residential Aged Care Facilities: Impact Of Age, Length Of Stay, Comorbidity, Frailty, And Dependence In Activities Of Daily Living.


Journal

Clinical interventions in aging
ISSN: 1178-1998
Titre abrégé: Clin Interv Aging
Pays: New Zealand
ID NLM: 101273480

Informations de publication

Date de publication:
2019
Historique:
received: 23 05 2019
accepted: 18 09 2019
entrez: 8 11 2019
pubmed: 7 11 2019
medline: 1 2 2020
Statut: epublish

Résumé

To explore variation in medication regimen complexity in residential aged care facilities (RACFs) according to resident age, length of stay, comorbidity, dementia severity, frailty, and dependence in activities of daily living (ADLs), and compare number of daily administration times and Medication Regimen Complexity Index (MRCI) as measures of regimen complexity. This study was a cross-sectional analysis of baseline data from the SImplification of Medications Prescribed to Long-tErm care Residents (SIMPLER) cluster-randomized controlled trial. The SIMPLER study recruited 242 residents with at least one medication charted for regular administration from 8 RACFs in South Australia. Comorbidity was assessed using the Charlson Comorbidity Index (CCI). Dementia severity was assessed using the Dementia Severity Rating Scale. Frailty was assessed using the FRAIL-NH scale. Dependence in ADLs was assessed using the Katz ADL scale. The median age of participants was 87 years (interquartile range 81-92). Over one-third of participants (n=86, 36%) had 5 or more daily medication administration times. The number of daily administration times and MRCI scores were positively correlated with resident length of stay (r Residents with longer lengths of stay, more dependent in ADLs and most frail had the most complex medication regimens and, therefore, may benefit from targeted strategies to reduce medication regimen complexity.

Identifiants

pubmed: 31695348
doi: 10.2147/CIA.S216705
pii: 216705
pmc: PMC6815218
doi:

Substances chimiques

Pharmaceutical Preparations 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1783-1795

Informations de copyright

© 2019 Chen et al.

Déclaration de conflit d'intérêts

This work was supported by the NHMRC Cognitive Decline Partnership Centre (grant number GNT9100000). The Cognitive Decline Partnership Centre receives support from the NHMRC and funding partners including Helping Hand Aged Care, HammondCare, Brightwater and Dementia Australia. The contents of the published materials are solely the responsibility of the individual authors identified, and do not reflect the views of the NHMRC and any other funding bodies or the funding partners. EYHC was supported by a postgraduate research scholarship funded by the Cognitive Decline Partnership Centre and the Monash University Faculty of Pharmacy and Pharmaceutical Sciences. JSB was supported by an NHMRC Dementia Research Leadership Fellowship. MC, MH and JvE are employed by Helping Hand Aged Care. JKS and JI were supported by NHMRC Early Career Fellowships. The authors report no other conflicts of interest in this work.

Références

Ann Pharmacother. 2004 Sep;38(9):1369-76
pubmed: 15266038
QJM. 2005 Dec;98(12):885-93
pubmed: 16284068
J Eval Clin Pract. 2016 Oct;22(5):677-82
pubmed: 26804719
J Gen Intern Med. 2001 Feb;16(2):77-82
pubmed: 11251757
Expert Opin Drug Saf. 2013 Nov;12(6):829-40
pubmed: 23984969
J Am Med Dir Assoc. 2015 Jun 1;16(6):535.e1-12
pubmed: 25869992
Int J Nurs Stud. 2017 Jul;72:15-23
pubmed: 28433827
Rev Clin Esp. 2018 Oct;218(7):342-350
pubmed: 29784546
Appl Clin Inform. 2014 Aug 27;5(3):773-88
pubmed: 25298816
J Gerontol A Biol Sci Med Sci. 2018 Jul 9;73(8):1090-1096
pubmed: 29985993
JAMA. 1963 Sep 21;185:914-9
pubmed: 14044222
Arch Gerontol Geriatr. 2018 Mar - Apr;75:202-208
pubmed: 29353187
J Gerontol Nurs. 2007 Apr;33(4):5-12
pubmed: 17436864
Patient Prefer Adherence. 2012;6:679-84
pubmed: 23055701
J Clin Pharm Ther. 2019 Aug;44(4):595-602
pubmed: 30793340
Qual Saf Health Care. 2009 Oct;18(5):341-6
pubmed: 19812095
Clin Interv Aging. 2018 May 18;13:975-986
pubmed: 29844664
Clin Ther. 2013 Apr;35(4):385-398.e1
pubmed: 23541707
Aust Health Rev. 2017 Dec;41(6):613-620
pubmed: 27888837
J Am Geriatr Soc. 2016 Nov;64(11):e207-e212
pubmed: 27783396
Patient Educ Couns. 2014 Jul;96(1):93-7
pubmed: 24793007
Drug Saf. 2013 Jan;36(1):31-41
pubmed: 23315294
Eur J Clin Pharmacol. 2015 Sep;71(9):1099-108
pubmed: 26071278
Am J Epidemiol. 2011 Mar 15;173(6):676-82
pubmed: 21330339
Alzheimer Dis Assoc Disord. 2009 Jul-Sep;23(3):268-74
pubmed: 19812470
J Am Med Dir Assoc. 2016 Nov 1;17(11):1067.e1-1067.e6
pubmed: 27780570
J Clin Pharm Ther. 2012 Dec;37(6):637-42
pubmed: 22607618
Int J Clin Pharm. 2014 Aug;36(4):750-6
pubmed: 24906719
Med J Aust. 2014 Oct 6;201(7):390-2
pubmed: 25296059
Ann Pharmacother. 2013 Feb;47(2):237-56
pubmed: 23386063
Trials. 2018 Jan 12;19(1):37
pubmed: 29329559
J Am Med Dir Assoc. 2015 Feb;16(2):87-9
pubmed: 25556303
Int J Clin Pharm. 2013 Apr;35(2):217-24
pubmed: 23212732
Am J Med. 2017 Aug;130(8):927-936.e9
pubmed: 28454668
BMC Pharmacol Toxicol. 2017 Jul 25;18(1):59
pubmed: 28743294
Eur J Clin Pharmacol. 2016 Sep;72(9):1117-24
pubmed: 27251360
Pharmacol Res. 2017 Feb;116:20-28
pubmed: 27965033
Ann Pharmacother. 2016 Feb;50(2):89-95
pubmed: 26681444
Am J Health Syst Pharm. 2013 Jun 15;70(12):1052-6
pubmed: 23719883
Alzheimer Dis Assoc Disord. 1996 Spring;10(1):31-9
pubmed: 8919494
Ann Pharmacother. 2016 Jul;50(7):534-40
pubmed: 27147704
BMJ Open. 2016 Mar 10;6(3):e009781
pubmed: 26966056
Arch Intern Med. 2011 Feb 28;171(4):300-5
pubmed: 21357804
BMC Fam Pract. 2012 Jul 09;13:56
pubmed: 22697490
J Am Med Inform Assoc. 2013 May 1;20(3):499-505
pubmed: 23268486
BMC Geriatr. 2011 Dec 07;11:82
pubmed: 22151472
J Pharm Technol. 2012 Jul 1;28(4):156-162
pubmed: 24660166
Eur J Clin Pharmacol. 2016 Aug;72(8):995-1001
pubmed: 27075194
Clin Ther. 2003 Aug;25(8):2307-35; discussion 2306
pubmed: 14512137
Curr Clin Pharmacol. 2015;10(3):168-77
pubmed: 26338170
Ann Pharmacother. 2018 Nov;52(11):1117-1134
pubmed: 29756471
Postgrad Med. 2018 Aug;130(6):575-579
pubmed: 30091394

Auteurs

Esa Yh Chen (EY)

Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Parkville, VIC, Australia.
NHMRC Cognitive Decline Partnership Centre, Hornsby Ku-ring-gai Hospital, Hornsby, NSW, Australia.

J Simon Bell (JS)

Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Parkville, VIC, Australia.
NHMRC Cognitive Decline Partnership Centre, Hornsby Ku-ring-gai Hospital, Hornsby, NSW, Australia.
Department of Epidemiology and Preventive Medicine, School of Public Health and Preventative Medicine, Monash University, Melbourne, VIC, Australia.

Jenni Ilomaki (J)

NHMRC Cognitive Decline Partnership Centre, Hornsby Ku-ring-gai Hospital, Hornsby, NSW, Australia.
Department of Epidemiology and Preventive Medicine, School of Public Health and Preventative Medicine, Monash University, Melbourne, VIC, Australia.

Claire Keen (C)

Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Parkville, VIC, Australia.

Megan Corlis (M)

NHMRC Cognitive Decline Partnership Centre, Hornsby Ku-ring-gai Hospital, Hornsby, NSW, Australia.
Helping Hand Aged Care, North Adelaide, SA, Australia.

Michelle Hogan (M)

Helping Hand Aged Care, North Adelaide, SA, Australia.

Jan Van Emden (J)

NHMRC Cognitive Decline Partnership Centre, Hornsby Ku-ring-gai Hospital, Hornsby, NSW, Australia.
Helping Hand Aged Care, North Adelaide, SA, Australia.

Sarah N Hilmer (SN)

NHMRC Cognitive Decline Partnership Centre, Hornsby Ku-ring-gai Hospital, Hornsby, NSW, Australia.
Kolling Institute, Faculty of Medicine and Health, The University of Sydney and Royal North Shore Hospital, St Leonards, NSW, Australia.

Janet K Sluggett (JK)

Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Parkville, VIC, Australia.
NHMRC Cognitive Decline Partnership Centre, Hornsby Ku-ring-gai Hospital, Hornsby, NSW, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH